| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |